Cold ischemia or topical-ECMO for lung preservation
a randomized experimental study
Keywords:
Organ preservation, Reperfusion injury, Lung transplantation, Transplantation, homologous, Thoracic surgeryAbstract
CONTEXT AND OBJECTIVE: Lung preservation remains a challenging issue for lung transplantation groups. Along with the development of ex vivo lung perfusion, a new preservation method known as topical-ECMO (extracorporal membrane oxygenation) has been proposed. The present study compared topical-ECMO with cold ischemia (CI) for lung preservation in an ex vivo experimental model. DESIGN AND SETTING: Randomized experimental study, conducted at a public medical school. METHOD: Fourteen human lungs were retrieved from seven brain-dead donors that were considered unsuitable for transplantation. The lung bloc was divided and each lung was randomized to be preserved by means of topical-ECMO or CI (4-7 °C) for eight hours. These lungs were then reconnected to an ex vivo perfusion system for functional evaluation. Lung biopsies were obtained at three times. The functional variables assessed were oxygenation capacity (OC) and pulmonary artery pressure (PAP); and the histological variables were lung injury score (LIS) and apoptotic cell count (ACC). RESULTS: The mean OC was 468 mmHg (± 81.6) in the topical-ECMO group and 455.8 (± 54) for CI (P = 0.758). The median PAP was 140 mmHg (120-160) in the topical-ECMO group and 140 mmHg (140-150) for CI (P = 0.285). The mean LIS was 35.57 (± 4.5) in the topical-ECMO group and 33.86 (± 6.1) for CI (P = 0.367). The ACC was 25.00 (± 9.34) in the topical-ECMO group and 24.86 (± 10.374) for CI (P = 0.803). CONCLUSIONS: The present study showed that topical-ECMO was not superior to cold ischemia for up to eight hours of lung preservation.
Downloads
References
Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011. J Heart Lung Transplant. 2011;30(10):1104-22.
de Perrot M, Keshavjee S. Lung preservation. Ann Thorac Surg. 2002;74(2):629-31.
Unilateral lung transplantation for pulmonary fibrosis. Toronto Lung Transplant Group. N Eng J Med. 1986;314(18):1140-5.
Hardesty RL, Griffith BP. Autoperfusion of the heart and lungs for preservation during distant procurement. J Thorac Cardiovasc Surg. 1987;93(1):11-8.
Fraser CD Jr, Tamura F, Adachi H, et al. Donor core-cooling provides improved static preservation for heart-lung transplantation. Ann Thorac Surg. 1988;45(3):253-7.
Colquhoun IW, Kirk AJ, Au J, et al. Single-flush perfusion with modified Euro-Collins solution: experience in clinical lung preservation. J Heart Lung Transplant. 1992;11(4 Pt 2):S209-14.
Van Raemdonck D. Thoracic organs: current preservation technology and future prospects; part 1: lung. Curr Opin Organ Transplant. 2010;15(2):150-5.
Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg. 2003;76(1):244-52; discussion 252.
Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83(6):2191-4.
Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg. 2009;87(1):255-60.
Pêgo-Fernandes PM, de Medeiros IL, Mariani AW, et al. Ex vivo lung perfusion: early report of Brazilian experience. Transplant Proc. 2010;42(2):440-3.
Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27(12):1319-25.
Canzian M, de Matos Soeiro A, de Lima Taga MF, et al. Semiquantitative assessment of surgical lung biopsy: predictive value and impact on survival of patients with diffuse pulmonary infiltrate. Clinics (Sao Paulo). 2007;62(1):23-30.
Mariani AW, Medeiros IL, Pêgo-Fernandes PM, et al. Modelo experimental ex vivo com bloco pulmonar dividido [Ex vivo experimental model: split lung block technique]. J Bras Pneumol. 2011;37(6):791-5.
Wang LS, Yoshikawa K, Miyoshi S, et al. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J Thorac Cardiovasc Surg. 1989;98(3):333-42.
de Perrot M, Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg. 2004;16(4):300-8.
Wittwer T, Franke UF, Fehrenbach A, et al. Experimental lung transplantation: impact of preservation solution and route of delivery. J Heart Lung Transplant. 2005;24(8):1081-90.
Orens JB, Garrity ER Jr. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc. 2009;6(1):13-9.
Nakajima D, Chen F, Yamada T, et al. Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2012;31(2):187-93.
Fischer S, Cassivi SD, Xavier AM, et al. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg. 2000;231(3):424-31.
Fischer S, Maclean AA, Liu M, et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med. 2000;162(5):1932-9.
Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant. 2009;9(10):2262-9.
